Buisan, Nadia .
HRN: 24-58-32 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2024
CEFUROXIME 750MG (VIAL)
05/24/2024
05/31/2024
IV
750mg
Q8
UTI
Waiting Final Action
05/25/2024
METRONIDAZOLE 500MG (TAB)
05/25/2024
06/02/2024
IV
500mg
Q8h
Amoebiasis
Waiting Final Action